A 69-year-old woman with a previous vertebral fragility fracture is found to have a 10-year major osteoporotic fracture risk of 25% using FRAX. She is postmenopausal and has no contraindications to therapy. What is the most appropriate management?AReassure and no treatmentBAdvise calcium and vitamin D onlyCOffer Bisphosphonate therapy such as AlendronateDStart long-term systemic steroidsEStart Denosumab without considering BisphosphonatesCheck my answer